Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma

Contents
3.3.4. Sensory changes at the contralateral side in relation to sensory
changes at the affected side
3.3.5. Correlation between background pain and QST parameters
3.3.6. Correlation between numbers of sensory abnormalities at the
affected and contralateral side
4. Discussion
4.1. Somatosensory function in healthy controls
4.2. Sensory signs at the affected, painful side of neuropathic pain patients
4.3. Contralateral sensory signs in neuropathic pain patients
4.4. Correlation between sensory changes at affected and contralateral side
Acknowledgement `
Chapter 3
Somatosensory profiles but not numbers of somatosensory abnormalities
of neuropathicpain patients correspond with neuropathic pain grading
Abstract
1. Introduction
2. Methods
2.1. Description of healthy controls
2.2. Description of the patient cohort
2.3. Quantitative sensory testing (QST)
2.4. Neuropathic pain grading
2.5. Data analysis and statistics
2.5.1. Z-transformation of QST data
2.5.2. Proportions of sensory signs for the different neuropathic pain grades
2.5.3. Correlation between the number of sensory abnormalities and
neuropathic pain grades
2.5.4. Correlation between background pain and neuropathic pain grades
3. Results
3.1. QST observations in healthy controls
3.1.1. Sensory loss and/or gain of function
3.2. Demographics of patients
3.2.1. Clinical diagnose of neuropathic pain
3.2.2. Grading of neuropathic pain
3.3. Type of sensory abnormalities in relation to neuropathic pain grading
3.3.1. Sensory loss and/or gain of function
3.3.2. Individual QST parameters
39
41
41
41
41
42
42
44
45
47
48
49
50
50
50
51
51
52
52
52
52
53
53
53
53
54
54
57
57
57
57